Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast

Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Market Cap	Price	Price Target	Upside/Downside	Consensus	Analysts	Fore. Revenue Growth	Fore. Earnings Growth	Forecast ROE	Forecast ROA
ADCT	ADC THERAPEUTICS SA	$339.54M	$4.10	$9.00	119.51%	Strong Buy	3	18.03%	N/A	N/A	N/A
KPTI	KARYOPHARM THERAPEUTICS INC	$135.37M	$1.15	$8.00	595.65%	Buy	1	20.13%	N/A	N/A	N/A
LBPH	LONGBOARD PHARMACEUTICALS INC	$804.43M	$20.69	$43.67	111.05%	Strong Buy	6	N/A	N/A	N/A	N/A
NXGL	NEXGEL INC	$14.73M	$2.37	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FBRX	FORTE BIOSCIENCES INC	$21.90M	$0.60	$2.75	357.57%	Strong Buy	1	N/A	N/A	N/A	N/A
ITOS	ITEOS THERAPEUTICS INC	$652.02M	$18.05	$36.50	102.22%	Strong Buy	2	N/A	N/A	N/A	N/A
ETNB	89BIO INC	$849.05M	$8.63	$27.00	212.86%	Buy	5	N/A	N/A	N/A	N/A
PIRS	PIERIS PHARMACEUTICALS INC	$14.48M	$10.97	N/A	N/A	N/A	N/A	-29.51%	N/A	N/A	N/A
NUVL	NUVALENT INC	$4.58B	$70.88	$101.43	43.10%	Strong Buy	7	N/A	N/A	N/A	N/A
IGC	IGC PHARMA INC	$35.69M	$0.56	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IONM	ASSURE HOLDINGS CORP	$3.84M	$0.43	N/A	N/A	N/A	N/A	23,970.59%	N/A	-645.58%	1,317.54%
AVNS	AVANOS MEDICAL INC	$935.98M	$20.39	N/A	N/A	N/A	N/A	4.28%	N/A	N/A	N/A
AEZS	AETERNA ZENTARIS INC	$10.34M	$8.52	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MYGN	MYRIAD GENETICS INC	$2.29B	$25.29	$27.25	7.75%	Strong Buy	4	7.86%	N/A	N/A	N/A
ABVX	ABIVAX SA	$858.35M	$13.64	$36.00	163.93%	Strong Buy	3	7.79%	N/A	N/A	N/A
KRMD	KORU MEDICAL SYSTEMS INC	$104.34M	$2.28	$3.50	53.51%	Strong Buy	2	13.08%	N/A	N/A	N/A
JSPR	JASPER THERAPEUTICS INC	$347.27M	$23.02	$70.00	204.08%	Buy	4	N/A	N/A	N/A	N/A
XGN	EXAGEN INC	$32.66M	$1.88	$7.00	272.34%	Strong Buy	1	-0.51%	N/A	N/A	N/A
CYTO	ALTAMIRA THERAPEUTICS LTD	$2.31M	$1.56	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PULM	PULMATRIX INC	$6.98M	$1.91	N/A	N/A	N/A	N/A	8.41%	N/A	N/A	N/A
VKTX	VIKING THERAPEUTICS INC	$7.39B	$67.00	$112.38	67.72%	Strong Buy	8	N/A	N/A	N/A	N/A
GTBP	GT BIOPHARMA INC	$4.42M	$3.12	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ENTA	ENANTA PHARMACEUTICALS INC	$256.91M	$12.13	$20.25	66.94%	Hold	4	0.42%	N/A	N/A	N/A
OCX	ONCOCYTE CORP	$39.16M	$2.93	$4.42	50.75%	Buy	3	N/A	N/A	322.93%	52.73%
XTNT	XTANT MEDICAL HOLDINGS INC	$93.76M	$0.72	$3.00	316.67%	Strong Buy	1	N/A	N/A	N/A	N/A
HCAT	HEALTH CATALYST INC	$410.29M	$6.95	$12.50	79.86%	Strong Buy	8	7.86%	N/A	N/A	N/A
VERA	VERA THERAPEUTICS INC	$2.26B	$41.39	$38.50	-6.98%	Strong Buy	6	N/A	N/A	N/A	N/A
RLAY	RELAY THERAPEUTICS INC	$881.40M	$6.64	$22.20	234.34%	Strong Buy	5	-8.13%	N/A	N/A	N/A
ALRN	AILERON THERAPEUTICS INC	$81.39M	$3.77	$19.00	403.98%	Strong Buy	1	N/A	N/A	-160.74%	-148.00%
PCVX	VAXCYTE INC	$8.11B	$74.57	$96.00	28.74%	Strong Buy	3	N/A	N/A	N/A	N/A
GHRS	GH RESEARCH PLC	$655.55M	$12.60	$36.67	191.01%	Strong Buy	3	N/A	N/A	N/A	N/A
RCM	R1 RCM INC	$5.24B	$12.43	$15.83	27.38%	Buy	12	12.04%	N/A	N/A	N/A
MLSS	MILESTONE SCIENTIFIC INC	$52.67M	$0.68	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RBOT	VICARIOUS SURGICAL INC	$62.12M	$0.42	$0.80	89.57%	Hold	2	N/A	N/A	N/A	N/A
DMTK	DERMTECH INC	$17.45M	$0.50	$1.38	175.95%	Buy	3	26.40%	N/A	-152.99%	-59.42%
NKTR	NEKTAR THERAPEUTICS	$322.26M	$1.76	$1.00	-43.02%	Hold	1	-12.45%	N/A	N/A	N/A
ESTA	ESTABLISHMENT LABS HOLDINGS INC	$1.56B	$56.57	$57.00	0.76%	Strong Buy	5	26.92%	N/A	N/A	N/A
ABUS	ARBUTUS BIOPHARMA CORP	$562.38M	$2.98	$4.33	45.40%	Strong Buy	3	-16.67%	N/A	N/A	N/A
QNCX	QUINCE THERAPEUTICS INC	$39.11M	$0.91	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TBIO	TELESIS BIO INC	$7.57M	$4.50	N/A	N/A	N/A	N/A	24.21%	N/A	N/A	N/A
GKOS	GLAUKOS CORP	$5.53B	$109.79	$108.64	-1.05%	Strong Buy	11	18.70%	N/A	N/A	N/A
PRPH	PROPHASE LABS INC	$95.97M	$5.03	$11.00	118.69%	Buy	1	91.36%	N/A	N/A	N/A
MYO	MYOMO INC	$104.89M	$3.64	$6.50	78.57%	Buy	1	N/A	N/A	N/A	N/A
NVCR	NOVOCURE LTD	$2.37B	$21.99	$24.80	12.78%	Buy	5	8.00%	N/A	N/A	N/A
AYTU	AYTU BIOPHARMA INC	$16.37M	$2.94	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ADAP	ADAPTIMMUNE THERAPEUTICS PLC	$284.24M	$1.11	$3.00	170.27%	Strong Buy	1	116.95%	N/A	N/A	N/A
GHSI	GUARDION HEALTH SCIENCES INC	$10.93M	$8.51	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TDOC	TELADOC HEALTH INC	$2.16B	$12.73	$18.68	46.73%	Buy	14	2.83%	N/A	N/A	N/A
JYNT	JOINT CORP	$257.85M	$17.22	$18.00	4.53%	Strong Buy	2	-11.88%	N/A	N/A	N/A
IBRX	IMMUNITYBIO INC	$5.29B	$7.65	$6.00	-21.57%	Hold	1	1,094.64%	N/A	N/A	N/A
DRRX	DURECT CORP	$28.87M	$0.93	$5.00	437.63%	Buy	1	42.51%	N/A	N/A	N/A
DOMH	DOMINARI HOLDINGS INC	$12.83M	$2.14	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LIVN	LIVANOVA PLC	$3.36B	$61.96	$69.75	12.57%	Buy	4	4.41%	N/A	N/A	N/A
BKD	BROOKDALE SENIOR LIVING INC	$1.33B	$6.91	$7.50	8.54%	Buy	2	N/A	N/A	-6.71%	-0.45%
AVDL	AVADEL PHARMACEUTICALS PLC	$1.49B	$15.49	$24.17	56.02%	Strong Buy	6	92.27%	N/A	N/A	N/A
SCLX	SCILEX HOLDING CO	$163.07M	$0.90	$8.00	788.89%	Buy	1	41.78%	N/A	N/A	N/A
SLN	SILENCE THERAPEUTICS PLC	$1.01B	$23.00	$57.25	148.91%	Strong Buy	4	5.83%	N/A	N/A	N/A
TVTX	TRAVERE THERAPEUTICS INC	$461.34M	$6.06	$13.17	117.28%	Buy	6	32.62%	N/A	N/A	N/A
VBIV	VBI VACCINES INC	$18.07M	$0.63	N/A	N/A	N/A	N/A	83.34%	N/A	N/A	N/A
MGRM	MONOGRAM ORTHOPAEDICS INC	$65.56M	$2.07	N/A	N/A	N/A	N/A	466.82%	N/A	N/A	N/A
PYPD	POLYPID LTD	$7.14M	$4.32	$14.00	224.45%	Buy	1	N/A	N/A	N/A	N/A
NTRB	NUTRIBAND INC	$49.04M	$4.47	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BTAI	BIOXCEL THERAPEUTICS INC	$77.69M	$2.07	$7.00	238.16%	Strong Buy	4	185.47%	N/A	N/A	N/A
ASND	ASCENDIS PHARMA A	$7.05B	$121.12	$186.00	53.57%	Strong Buy	7	49.27%	N/A	N/A	N/A
RDHL	REDHILL BIOPHARMA LTD	$18.13M	$0.47	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DH	DEFINITIVE HEALTHCARE CORP	$867.34M	$5.50	$8.42	53.04%	Hold	6	3.96%	N/A	N/A	N/A
CDMO	AVID BIOSERVICES INC	$578.94M	$9.12	$12.50	37.06%	Strong Buy	4	31.10%	N/A	N/A	N/A
MOR	MORPHOSYS AG	$2.86B	$19.00	$12.13	-36.18%	Buy	4	28.17%	N/A	N/A	N/A
HROW	HARROW INC	$593.00M	$16.76	$29.00	73.03%	Strong Buy	1	35.90%	N/A	N/A	N/A
AIH	AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LTD	$23.82M	$0.50	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RNLX	RENALYTIX PLC	$39.60M	$0.51	N/A	N/A	N/A	N/A	102.61%	N/A	N/A	N/A
ATRA	ATARA BIOTHERAPEUTICS INC	$73.45M	$0.61	$2.30	277.05%	Hold	1	155.29%	N/A	N/A	N/A
BBIO	BRIDGEBIO PHARMA INC	$5.63B	$30.09	$49.71	65.22%	Strong Buy	7	37.91%	N/A	N/A	N/A
TCRX	TSCAN THERAPEUTICS INC	$474.71M	$8.98	$11.40	26.95%	Strong Buy	5	-10.76%	N/A	N/A	N/A
AZTA	AZENTA INC	$2.74B	$50.87	$68.40	34.46%	Buy	5	4.57%	N/A	N/A	N/A
XAIR	BEYOND AIR INC	$49.37M	$1.37	$8.00	483.94%	Strong Buy	1	395.40%	N/A	N/A	N/A
NDRA	ENDRA LIFE SCIENCES INC	$3.39M	$0.31	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DYNT	DYNATRONICS CORP	$2.24M	$0.42	N/A	N/A	N/A	N/A	7.18%	N/A	N/A	N/A
PTIX	PROTAGENIC THERAPEUTICS INC	$6.65M	$1.50	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LCTX	LINEAGE CELL THERAPEUTICS INC	$203.90M	$1.08	$6.50	501.85%	Strong Buy	2	N/A	N/A	N/A	N/A
ENLV	ENLIVEX THERAPEUTICS LTD	$26.22M	$1.41	$7.00	396.45%	Buy	1	N/A	N/A	N/A	N/A
INSM	INSMED INC	$3.68B	$24.77	$45.55	83.87%	Strong Buy	11	35.65%	N/A	N/A	N/A
BVS	BIOVENTUS INC	$507.94M	$6.38	$8.50	33.23%	Strong Buy	2	4.18%	N/A	N/A	N/A
GLSI	GREENWICH LIFESCIENCES INC	$180.04M	$13.98	$36.00	157.51%	Buy	1	N/A	N/A	N/A	N/A
TIL	INSTIL BIO INC	$74.80M	$11.50	$20.33	76.81%	Buy	3	N/A	N/A	N/A	N/A
PTPI	PETROS PHARMACEUTICALS INC	$4.10M	$0.59	$4.00	582.59%	Strong Buy	1	N/A	N/A	N/A	N/A
BIO	BIO-RAD LABORATORIES INC	$8.38B	$293.85	$410.00	39.53%	Buy	3	4.91%	N/A	N/A	N/A
CMND	CLEARMIND MEDICINE INC	$3.87M	$1.22	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
INZY	INOZYME PHARMA INC	$284.54M	$4.60	$17.00	269.57%	Strong Buy	4	N/A	N/A	N/A	N/A
VRCA	VERRICA PHARMACEUTICALS INC	$367.78M	$8.67	$13.33	53.78%	Strong Buy	3	156.33%	N/A	N/A	N/A
CERT	CERTARA INC	$2.59B	$16.08	$19.10	18.78%	Hold	5	9.20%	N/A	N/A	N/A
GNTA	GENENTA SCIENCE SPA	$60.12M	$3.30	$25.00	657.58%	Buy	1	N/A	N/A	N/A	N/A
ZIMV	ZIMVIE INC	$464.45M	$17.02	$16.00	-5.99%	Sell	2	143.36%	N/A	N/A	N/A
RLYB	RALLYBIO CORP	$73.37M	$1.77	$8.90	402.82%	Buy	5	N/A	N/A	N/A	N/A
UBX	UNITY BIOTECHNOLOGY INC	$24.85M	$1.48	$8.00	440.54%	Buy	1	N/A	N/A	N/A	N/A
PDSB	PDS BIOTECHNOLOGY CORP	$128.01M	$3.49	$16.00	358.45%	Strong Buy	2	N/A	N/A	N/A	N/A
BMEA	BIOMEA FUSION INC	$439.96M	$12.24	$55.80	355.88%	Buy	5	N/A	N/A	N/A	N/A
VOR	VOR BIOPHARMA INC	$123.55M	$1.81	$12.50	590.61%	Buy	5	N/A	N/A	N/A	N/A
SRRK	SCHOLAR ROCK HOLDING CORP	$996.13M	$12.49	$27.00	116.17%	Strong Buy	4	N/A	N/A	N/A	N/A
CELC	CELCUITY INC	$523.42M	$16.76	$29.50	76.01%	Strong Buy	4	N/A	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	679	-0.70%	+1.84%	+3.96%	-19.69%	8.47x	6.01x	+18.62%	+3.83%	-27.52%	+77.73%	Strong Buy
Diagnostics & Research	64	-0.44%	+1.56%	+12.99%	+11.25%	38.96x	4.47x	-13.18%	+6.48%	+11.49%	+5.02%	Buy
Drug Manufacturers - General	18	-0.03%	+1.66%	+7.51%	+18.11%	31.85x	6.42x	+33.60%	+8.10%	+14.22%	+11.01%	Buy
Drug Manufacturers - Specialty & Generic	87	-0.75%	+1.10%	+5.60%	-1.99%	-1.01x	2.20x	+12.36%	+3.36%	+6.05%	+32.29%	Strong Buy
Healthcare Plans	12	+0.52%	+1.22%	+4.66%	+4.46%	25.53x	3.07x	+15.18%	+4.74%	+11.78%	+11.78%	Buy
Health Information Services	61	+0.25%	+2.04%	-0.03%	-19.66%	9.15x	3.33x	+6.71%	+2.23%	+5.33%	+26.88%	Buy
Medical Care Facilities	51	-0.09%	+0.01%	+4.96%	+11.10%	39.23x	4.59x	-92.23%	+6.58%	+13.66%	+15.22%	Buy
Medical Devices	150	-0.35%	+1.37%	+2.08%	-13.46%	30.60x	4.00x	+7.35%	+5.26%	+8.26%	+19.86%	Buy
Medical Distribution	10	+0.87%	+0.34%	+1.16%	+26.37%	26.84x	107.17x	-11.87%	+3.44%	+19.58%	+10.98%	Buy
Medical Instruments & Supplies	56	+0.16%	+1.85%	+6.62%	-5.76%	59.83x	3.64x	+11.25%	+7.73%	+10.05%	+18.23%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 46 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -42.43% over the past year, underperforming other healthcare stocks by -37 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 33.84% from Cross Country Healthcare's current stock price of $14.57.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the second best healthcare stock with a Zen Score of 67, which is 43 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 14.93% over the past year, overperforming other healthcare stocks by 21 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 44.77% from Corcept Therapeutics's current stock price of $28.09.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Kamada (NASDAQ:KMDA)

Kamada (NASDAQ:KMDA) is the third best healthcare stock with a Zen Score of 65, which is 41 points higher than the healthcare sector average of 24. It passed 20 out of 33 due diligence checks and has strong fundamentals. Kamada has seen its stock return 12.82% over the past year, overperforming other healthcare stocks by 19 percentage points.

Kamada has an average 1 year price target of $11.00, an upside of 104.84% from Kamada's current stock price of $5.37.

Kamada stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Kamada, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Sanofi (NASDAQ:SNY)

Sanofi (NASDAQ:SNY) has an annual dividend yield of 8.1%, which is 6 percentage points higher than the healthcare sector average of 2.05%. Sanofi's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Sanofi's dividend has shown consistent growth over the last 10 years.

Sanofi's dividend payout ratio of 82.1% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.93%, which is 6 percentage points higher than the healthcare sector average of 2.05%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 7.88%, which is 6 percentage points higher than the healthcare sector average of 2.05%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.28% in the last day, and up 1.47% over the last week. Heart Test Laboratories was the among the top losers in the healthcare sector, dropping -38.37% yesterday.

Heart Test Laboratories shares are trading lower after the company's 1-for-100 reverse stock split began trading on a split-adjusted basis.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -44.03% in the past year. It has underperformed other stocks in the healthcare sector by -38 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -23.81% in the past year. It has underperformed other stocks in the healthcare sector by -18 percentage points.

3. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Cross Country Healthcare has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Cross Country Healthcare's stock has dropped -42.43% in the past year. It has underperformed other stocks in the healthcare sector by -37 percentage points.

Are healthcare stocks a good buy now?

50.29% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 32.6% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.53x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.